Last reviewed · How we verify
INDIUM PENTETREOTIDE
INDIUM PENTETREOTIDE is a drug. It is currently FDA-approved (first approved 1994).
At a glance
| Generic name | INDIUM PENTETREOTIDE |
|---|---|
| Modality | Recombinant protein |
| Phase | FDA-approved |
| First approval | 1994 |
Approved indications
Common side effects
Key clinical trials
- 68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs) (NA)
- Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors (PHASE2, PHASE3)
- Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT (PHASE2)
- New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome (PHASE2)
- Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis (NA)
- Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor (PHASE3)
- Study to Evaluate the Effect of Age (Geriatric) and Kidney Function on the Safety, Efficacy and Pharmacokinetics of OctreoScan in Patients Who Have New or Recurrent Tumors (PHASE4)
- Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- INDIUM PENTETREOTIDE CI brief — competitive landscape report
- INDIUM PENTETREOTIDE updates RSS · CI watch RSS
Frequently asked questions about INDIUM PENTETREOTIDE
What is INDIUM PENTETREOTIDE?
INDIUM PENTETREOTIDE is a Recombinant protein drug.
When was INDIUM PENTETREOTIDE approved?
INDIUM PENTETREOTIDE was first approved on 1994.
What development phase is INDIUM PENTETREOTIDE in?
INDIUM PENTETREOTIDE is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing